Antibody–drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes-Reference-Cited by-同舟云学术

Antibody–drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes

Published:2018-11-27 Issue:5 Volume:234 Page:5628-5642
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Abdollahpour‐Alitappeh Meghdad¹²^ORCID,Lotfinia Majid³,Gharibi Tohid⁴⁵,Mardaneh Jalal⁶,Farhadihosseinabadi Behrouz⁷,Larki Pegah³,Faghfourian Babak⁸,Sepehr Koushan Sineh⁹,Abbaszadeh‐Goudarzi Kazem¹⁰,Abbaszadeh‐Goudarzi Ghasem¹¹¹²,Johari Behrooz¹³,Zali Mohammad Reza³,Bagheri Nader¹⁴

Affiliation:

1. Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL) Baqiyatallah University of Medical Sciences Tehran Iran

2. Department of Nursing, School of Nursing, Larestan University of Medical Sciences Larestan Iran

3. Gastroenterology and Liver Diseases Research Center Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences Tehran Iran

4. Immunology Research Center Tabriz University of Medical Sciences Tabriz Iran

5. Department of Immunology, Faculty of Medicine Tabriz University of Medical Sciences Tabriz Iran

6. Department of Microbiology School of Medicine, Gonabad University of Medical Sciences Gonabad Iran

7. Department of Pharmacology School of Medicine, Shahid Beheshti University of Medical Sciences Tehran Iran

8. Department of Cardiology School of Medicine, Hamedan University of Medical Sciences Hamedan Iran

9. Laboratory Sciences Research Center Golestan University of Medical Sciences Gorgan Iran

10. Cellular and Molecular Research Center Sabzevar University of Medical Sciences Sabzevar Iran

11. Department of Medical Biotechnology School of Medicine, Shahroud University of Medical Sciences Shahroud Iran

12. Cancer Prevention Research Center Shahroud University of Medical Sciences Shahroud Iran

13. Department of Medical Biotechnology and Nanotechnology School of Medicine, Zanjan University of Medical Science Zanjan Iran

14. Cellular and Molecular Research Center Basic Health Sciences Institute, Shahrekord University of Medical Sciences Shahrekord Iran

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.27419

Reference121 articles.

1. A developed antibody–drug conjugate rituximab-vcMMAE shows a potent cytotoxic activity against CD20-positive cell line

2. Evaluation of Factors Influencing Antibody Reduction for Development of Antibody Drug Conjugates

3. Impact of linker and conjugation chemistry on antigen binding, Fc receptor binding and thermal stability of model antibody-drug conjugates

4. Recombinant Antibodies as Therapeutic Agents

5. The Pharmacologic Basis for Antibody-Auristatin Conjugate Activity

Cited by 177 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging trends and therapeutic applications of monoclonal antibodies;Gene;2024-10

2. Advances in immunotoxin engineering: precision therapeutic strategies in modern oncology;Medical Oncology;2024-09-04

3. Nectin-4-directed antibody-drug conjugates (ADCs): Spotlight on preclinical and clinical evidence;Life Sciences;2024-09

4. Research progress of antibody–drug conjugates in gynecologic cancer;Holistic Integrative Oncology;2024-08-29

5. Antibody Drug Conjugates for Cancer Therapy: From Metallodrugs to Nature-Inspired Payloads;International Journal of Molecular Sciences;2024-08-08